Literature DB >> 7500274

USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations.

B R Rohrs1, D L Burch-Clark, M J Witt, D J Stelzer.   

Abstract

The United States Pharmacopoeia dissolution apparatus 3 (reciprocating cylinder) was evaluated with respect to effects of changes in instrument parameters on drug release rate from six hydrophilic matrix formulations and one coated-bead formulation. Reciprocation rate had the largest effect on time to 50% release for all matrix formulations. Top mesh size had an effect on release rate for those formulations having an erosion component to the drug release mechanism. Bottom mesh size had no effect on release rate. For the coated-bead formulation, no parameter had an effect on release rate. In an assessment of the hydrodynamics of the reciprocating cylinders, conditions equivalent to the 50 rpm paddle and 100 rpm basket were determined to be at the extreme low end of the available reciprocation rate range.

Mesh:

Substances:

Year:  1995        PMID: 7500274     DOI: 10.1002/jps.2600840804

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Evaluation of USP apparatus 3 for dissolution testing of immediate-release products.

Authors:  Lawrence X Yu; Jin T Wang; Ajaz S Hussain
Journal:  AAPS PharmSci       Date:  2002

2.  Understanding biorelevant drug release from a novel thermoplastic capsule by considering microstructural formulation changes during hydration.

Authors:  Zdravka Misic; Raphael Urbani; Thomas Pfohl; Katharina Muffler; Georg Sydow; Martin Kuentz
Journal:  Pharm Res       Date:  2013-08-07       Impact factor: 4.200

3.  Computational fluid dynamics simulation of hydrodynamics in USP apparatus 3-the influence of dip rate.

Authors:  Satish Perivilli; Maziar Kakhi; Erika Stippler
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

4.  A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the correlation with the in vivo data.

Authors:  Uroš Klančar; Boštjan Markun; Saša Baumgartner; Igor Legen
Journal:  AAPS J       Date:  2012-11-28       Impact factor: 4.009

5.  Use of in vitro-in vivo correlation to predict the pharmacokinetics of several products containing a BCS class 1 drug in extended release matrices.

Authors:  Tahseen Mirza; Srikant A Bykadi; Christopher D Ellison; Yongsheng Yang; Barbara M Davit; Mansoor A Khan
Journal:  Pharm Res       Date:  2012-08-22       Impact factor: 4.200

6.  Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.

Authors:  Uroš Klančar; Saša Baumgartner; Igor Legen; Polona Smrdel; Nataša Jeraj Kampuš; Dejan Krajcar; Boštjan Markun; Klemen Kočevar
Journal:  AAPS PharmSciTech       Date:  2014-10-18       Impact factor: 3.246

7.  In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III.

Authors:  Jinhe Li; Libo Yang; Sheila M Ferguson; Tom J Hudson; Shunsuke Watanabe; Masataka Katsuma; Joseph A Fix
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

8.  Velocity Field Visualization in USP Dissolution Apparatus 3 Using Particle Image Velocimetry.

Authors:  Satish Perivilli; Richard Prevost; Erika Stippler
Journal:  Pharm Res       Date:  2017-04-13       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.